Oragenics Stock Price - OGEN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 0.46 ▼ -0.00 (-0.65%)
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.016 3.58% 0.463 0.4998 0.4412 0.4603 0.447 19:19:50
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,494 424,831 $ 0.4701513 $ 199,735 1,326,965 0.35 - 1.67
Last Trade Time Type Quantity Stock Price Currency
18:29:43 308 $ 0.463 USD

Oragenics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 21.36M 46.12M $ -9.91M -0.90 - 37.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.61M $ - 0.00% 4.00 18.60%

more financials information »

Oragenics News

Loading Messages....

Latest OGEN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.4450.49980.420.4365368k0.0184.04%
1 Month0.610.690.420.55051M-0.147-24.10%
3 Months0.4780.690.350.5092839k-0.015-3.14%
6 Months0.570.70.350.51131M-0.107-18.77%
1 Year1.221.670.350.83252M-0.757-62.05%
3 Years4.207110.351.45181M-3.744-88.99%
5 Years9.938.70.352.2339750k-9.437-95.32%

Oragenics Description

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves in developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out licensing or partnering.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.